Intravitreal aflibercept for diabetic macular oedema: Moorfields’ real-world 12-month visual acuity and anatomical outcomesMarko Lukić, Ranjan Rajendram, Praveen J. Patel et al.|European Journal of Ophthalmology|2019Cited by 35
Diabetic Macular Oedema and Chronic Kidney Disease: Response to treatment with anti-vascular endothelial growth factor (VEGF)Alice Bruynseels, Ranjan Rajendram, Rita Pinto et al.|Investigative Ophthalmology & Visual Science|2016Cited by 0